![cancer cells chemotherapy - photo by Yissum](https://nocamels.com/wp-content/uploads/2017/05/Yissum-350x210.jpg)
Biotech Company That Can Predict Chemotherapy Effectiveness Raises $4M
The Jerusalem-based NewStem, a spinoff of Yissum, The Technology Transfer Company of Hebrew University, raised the seed financing round from a publicly-traded US-based company to be named NovelStem International Corp.
July 16, 2018